Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233.SZ) stock: key figures, P/E, revenue and dividend

Materials · Specialty Chemicals · China · ISIN CNE100001500

Price
11.49 CNY
Market cap
4.41 bn CNY
P/E (2025)
99.82
P/S (2025)
1.61
Dividend yield
1.31 %
Net margin
1.61 %
Return on equity (ROE)
1.21 %
Return on assets (ROA)
0.85 %

Shandong Jincheng Pharmaceutical and Chemical Co Ltd financials

Fiscal year20242025
Revenue3.37 bn CNY2.74 bn CNY
Gross profit1.30 bn CNY986.30 m CNY
Operating income267.14 m CNY136.63 m CNY
EBIT288.03 m CNY88.83 m CNY
Net income196.78 m CNY44.19 m CNY
Diluted EPS – continuing operations0.52 CNY0.12 CNY

Full history since 2008, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Shandong Jincheng Pharmaceutical and Chemical Co Ltd

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 03.11.2026. Details in the risk notice.